Back to Forecasting

HIMS Forecast Markets

Hims & Hers Health, Inc.

8
Active Markets
2
Resolved
39%
Avg Probability

All Markets

10 markets

Will HIMS report Q4 2025 weight loss specialty revenue below $175M?

Active
68%
Likely Yes
52%68%after Q4 2025 earnings
88% agreement
Mar 15, 2026
IG: 0.80

Will the DOJ file criminal charges against HIMS or any HIMS officer by September 30, 2026?

Active
19%
Likely No
21%19%after Q4 2025 earnings
94% agreement
Oct 15, 2026
IG: 0.80

Will HIMS report negative free cash flow (operating cash flow minus CapEx) for Q1 2026?

Active
38%
Likely No
91% agreement
Jun 15, 2026
IG: 0.79

Will HIMS Q1 2026 revenue fall below the guided floor of $600M?

Active
15%
Likely No
94% agreement
Jun 15, 2026
IG: 0.63

Will HIMS complete the Eucalyptus Health acquisition by September 30, 2026?

Active
76%
Likely Yes
86% agreement
Oct 15, 2026
IG: 0.63

Will the FDA publish final rules or take formal enforcement action restricting 503A compounding of semaglutide by June 30, 2026?

Active
60%
Likely Yes
65%60%after Q4 2025 earnings
89% agreement
Jul 15, 2026
IG: 0.60

Will a court grant Novo Nordisk a preliminary injunction against HIMS compounded semaglutide products by September 30, 2026?

Active
10%
Likely No
18%10%after Q4 2025 earnings
95% agreement
Oct 15, 2026
IG: 0.60

Will any HIMS insider make an open-market stock purchase by June 30, 2026?

Active
10%
Likely No
18%10%after Q4 2025 earnings
95% agreement
Jul 15, 2026
IG: 0.48

Will HIMS report Q4 2025 year-over-year subscriber growth below 15%?

Resolved
65%
Likely Yes
Actual: YES
Brier: 0.123
Feb 23, 2026
IG: 0.64

Will HIMS management withdraw or materially reduce its $6.5B 2030 revenue target at Q4 2025 earnings?

Resolved
28%
Likely No
Actual: NO
Brier: 0.078
Feb 23, 2026
IG: 0.48